knowledge -WSS

knowledge

author：comprehensive 2025-09-28 21:04:53 - browse：4

Jacob S. Van Naarden (left), Athena Countouriotis( center), and Vlad Coric (right) on stage at the 2023 STAT Summit. — From left, Eli Lilly's Jacob S. Van Naarden, Avenzo's Athena Countouriotis, and Biohaven's Vlad Coric on stage at the 2023 STAT Summit. STAT

What does it feel like to run a biotech startup and then get “the call” — the one from the big pharma CEO who wants to acquire your company for billions of dollars?

At the 2023 STAT Summit on Wednesday, senior biotech writer Adam Feuerstein posed this question to three people very qualified to answer it: Vlad Coric, chairman and CEO of Biohaven, which was acquired by Pfizer in 2022 for $11.6 billion; Jacob Van Naarden, former COO of Loxo Oncology, which was acquired by Eli Lilly (where Van Naarden is now executive vice president) for $8 billion in 2019; and Athena Countouriotis, whose company Turning Point Therapeutics was acquired by BMS for $4 billion in 2022.

“Imagine you’re going through your typical day, and you get a message: Albert Bourla, chairman and CEO of Pfizer, wants to talk at six o’clock tonight,” said Coric, whose company had a successful migraine drug on the market and had just completed an IPO at the time.

Get unlimited access to award-winning journalism and exclusive events.

Subscribe Log In

Previous article： Biden outlines 'new path' to provide student loan relief after Supreme Court rejection
Next article： Biden declares emergency in flood

explore

WSS

Brazil's Neymar fined $3.3 million for illegal artificial lake at mansion outside Rio

‘Insidious 5’ topples 'Indiana Jones' before ‘Mission: Impossible’ launches

Medicare wants to send $9 billion to 340B hospitals

Churchill Downs extends trainer Bob Baffert's ban through 2024

Tulsa Race Massacre survivors and attorneys respond to dismissal of lawsuit

DeSantis defends odds vs. Trump, despite early poll gap: 'We've worked really hard'

hotspot

knowledge

leisure time

Malaria cases in Florida and Texas: Here’s what you need to know

Eisai exec who led development of Alzheimer’s drug to retire

Alkermes shareholders re

Trump pressured former Arizona governor to overturn 2020 election results: Sources

Food as medicine: CMS rules hamper 'prescribing' of fruits, veggies

PlayStation controller and acoustic messaging: How the missing Titanic tourist sub works

Guidelines to prevent youth baseball injuries need more muscle

Legitimacy of 'customer' in Supreme Court gay rights case raises ethical, legal flags

State Dept. review finds Biden bears some blame for Afghanistan failures

Rikers Island jail violence not addressed, NYC should be held in contempt: Fed monitor

explore

Teachers share how revamped forgiveness program helped with their student loans

‘Insidious 5’ topples 'Indiana Jones' before ‘Mission: Impossible’ launches

Masked assailants attack a journalist and a lawyer in Russia's Chechnya province

Elon Musk announces 'temporary limits' for reading Twitter posts

NASA releases new images of 'fingerprint

Eisai exec who led development of Alzheimer’s drug to retire

focus

knowledge

explore

hotspot